マイクロ流体市場：材料、コンポーネント、用途、エンドユーザー別-2025-2030年の世界予測

マイクロ流体市場は、2023年に255億3,000万米ドルと評価され、2024年には318億4,000万米ドルに達すると予測され、CAGR 25.37％で成長し、2030年には1,243億1,000万米ドルになると予測されています。

マイクロ流体は、工学、物理学、化学、生化学、ナノテクノロジー、バイオテクノロジーが交差する学際的分野であり、マイクロチャンネル内の少量の流体を操作することを含みます。その範囲は、医薬品開発、臨床診断、環境モニタリングなど様々な用途に及び、ヘルスケア、製薬、環境科学などの産業に貢献しています。マイクロ流体の必要性は、サンプルや試薬の量を減らして高効率でコスト効率の高い分析を行い、迅速に結果を出すことができることにあります。その用途は多岐にわたるが、特にポイントオブケア検査、病原体検出、個別化医療において極めて重要であり、ヘルスケアサービスの分散化と迅速診断の需要の高まりに後押しされています。

マイクロ流体市場に影響を与える主な成長要因には、小型化技術の進歩、研究開発資金の増加、革新的な診断ソリューションが必要とされる慢性疾患の有病率の上昇などがあります。マイクロ流体とAIおよび機械学習の統合は、特にスマートで自律的なラボオンチップデバイスの開発において、大きなビジネスチャンスをもたらします。このような機会を生かすために、利害関係者は学際的なコラボレーションに注力し、自動化とデジタル化の能力を拡大すべきです。

しかし、デバイスの高コスト、複雑な製造プロセス、厳しい規制要件などの課題は、市場の成長を阻害する可能性があります。こうした制約を克服するには、拡張性のある製造技術と規制経路の合理化に対する戦略的投資が必要となります。イノベーションが必要とされる分野には、在宅ヘルスケア環境向けの低コストで使いやすいマイクロ流体システムの開発や、持続可能性とコスト削減のための紙ベースのマイクロ流体のような新素材の探求などがあります。

急速な技術革新と高度な競争を特徴とするマイクロ流体市場は、大きな成長が期待できます。企業は、製品ポートフォリオと地理的なリーチを強化するために、戦略的な合併や買収を狙うべきです。ポータブルかつ迅速な診断ソリューションへの需要が高まる中、感度と特異性を高めた統合システムの開拓を重視することで、進化する市場環境において主導権を握ることができます。

市場力学：急速に進化するマイクロ流体市場の主要市場インサイトを公開

マイクロ流体市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 慢性疾患の罹患率の増加とポイントオブケア検査需要の増加
  • マイクロ流体チップの小型化によるデバイスの可搬性の向上と分析時間の短縮化
  • マイクロ流体を用いたドラッグデリバリーの応用可能性
• 市場抑制要因
  • 複雑で時間のかかる規制当局の承認プロセス
• 市場機会
  • Organ-on-a-Chipのようなマイクロ流体ベースの3D細胞培養システムの開発
  • バイオメディカル分析・診断用マイクロ流体コンポーネントの進歩
• 市場の課題
  • マイクロ流体と既存のワークフローとの統合

ポーターの5つの力：マイクロ流体市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、マイクロ流体市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：マイクロ流体市場における外部からの影響の把握

外部マクロ環境要因は、マイクロ流体市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析マイクロ流体市場における競合情勢の把握

マイクロ流体市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスマイクロ流体市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、マイクロ流体市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限はベンダーを明確かつ正確に区分し、ユーザーが戦略目標に最適なパートナーやソリューションを特定するのに役立ちます。

本レポートは、主要な注目分野を網羅した包括的な市場分析を提供しています：

1.市場の浸透度：業界主要企業の広範なデータを含む、現在の市場環境の詳細なレビュー。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患の増加とポイントオブケア検査の需要増加
    • マイクロ流体チップの小型化によるデバイスの携帯性の向上と分析のターンアラウンド時間の短縮
    • マイクロ流体を使用したドラッグデリバリーの潜在的な用途
  • 抑制要因
    • 複雑で時間のかかる規制承認プロセス
  • 機会
    • オルガンオンチップなどのマイクロ流体ベースの3D細胞培養システムの開発
    • バイオメディカル分析および診断のためのマイクロ流体コンポーネントの進歩
  • 課題
    • マイクロ流体と既存のワークフローの統合
• 市場セグメンテーション分析
  • 材料：マイクロ流体デバイスにおけるガラスおよびシリコンベースの材料の使用増加
  • コンポーネント：感染リスクを最小限に抑えるためのマイクロニードルとポンプの採用
  • 応用：IVDおよび治療におけるマイクロ流体デバイスの重要な応用
  • エンドユーザー：調査機関、病院、診断センターにおけるマイクロ流体の新たな利用
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境
• 顧客のカスタマイズ

第6章 マイクロ流体市場：素材別

• ガラスベース
• ポリマーベース
• シリコンベース

第7章 マイクロ流体市場：コンポーネント別

• マイクロニードル
• マイクロポンプ
• マイクロ流体チップ

第8章 マイクロ流体市場：用途別

• 体外診断
  • 臨床診断
  • ポイントオブケア検査
  • 獣医診断
• 製薬およびライフサイエンス調査
  • ラボ分析
    • キャピラリー電気泳動
    • 細胞ベースのアッセイ
    • ゲノム解析
    • プロテオーム解析
  • マイクロディスペンシング
  • マイクロ反応
• 治療薬
  • ドラッグデリバリー
  • ウェアラブルデバイス

第9章 マイクロ流体市場：エンドユーザー別

• 学術調査機関
• 病院と診断センター
• 製薬・バイオテクノロジー企業

第10章 南北アメリカのマイクロ流体市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域のマイクロ流体市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのマイクロ流体市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • アストラベウス、自動化されたマイクロ流体細胞および遺伝子治療製造プラットフォームの開発を進めるため、シードラウンドで1,650万ユーロを調達
  • バイオテクネ、スイスの空間生物学企業ルナフォアを買収へ
  • CellFE、ASGCT 2023年次会議で新しいマイクロ流体細胞工学プラットフォームの発表を発表

企業一覧

• Abbott Laboratories
• Ascent Bio-Nano Technologies, Inc.
• Camozzi Automation S.p.A.
• Dolomite Microfluidics
• IMT Masks and Divisions AG
• PerkinElmer Inc.
• Thermo Fisher Scientific, Inc.
• Mission Bio, Inc.
• Idex Corporation
• NanoCellect Biomedical.
• Abaxis, Inc.
• Quidel Corporation
• Koninklijke Philips N.V.
• Parker-Hannifin Corporation
• Illumina, Inc.
• Bio-Rad Laboratories, Inc.
• BioFluidica
• Agilent Technologies, Inc.
• Danaher Corporation
• Biosurfit SA
• SMC Corporation
• Micropoint Bioscience, Inc.
• Fluigent S.A.
• Elvesys Group
• Achira Labs Pvt. Ltd.
• Sphere Fluidics Limited
• OPKO Health, Inc.
• Cellix Limited
• AbCellera Biologics Inc.
• Fluidigm Corporation by Standard BioTools Inc.

LIST OF FIGURES

• FIGURE 1. MICROFLUIDICS MARKET RESEARCH PROCESS
• FIGURE 2. MICROFLUIDICS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL MICROFLUIDICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL MICROFLUIDICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL MICROFLUIDICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL MICROFLUIDICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES MICROFLUIDICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES MICROFLUIDICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. MICROFLUIDICS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. MICROFLUIDICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. MICROFLUIDICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL MICROFLUIDICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL MICROFLUIDICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. MICROFLUIDICS MARKET DYNAMICS
• TABLE 7. GLOBAL MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL MICROFLUIDICS MARKET SIZE, BY GLASS-BASED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL MICROFLUIDICS MARKET SIZE, BY POLYMER-BASED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL MICROFLUIDICS MARKET SIZE, BY SILICON-BASED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL MICROFLUIDICS MARKET SIZE, BY MICRO NEEDLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL MICROFLUIDICS MARKET SIZE, BY MICRO PUMP, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL MICROFLUIDICS MARKET SIZE, BY MICROFLUIDIC CHIP, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL MICROFLUIDICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL MICROFLUIDICS MARKET SIZE, BY POINT-OF-CARE TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL MICROFLUIDICS MARKET SIZE, BY VETERINARY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL MICROFLUIDICS MARKET SIZE, BY CAPILLARY ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL MICROFLUIDICS MARKET SIZE, BY CELL-BASED ASSAYS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL MICROFLUIDICS MARKET SIZE, BY GENOMIC ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL MICROFLUIDICS MARKET SIZE, BY PROTEOMIC ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL MICROFLUIDICS MARKET SIZE, BY MICRODISPENSING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL MICROFLUIDICS MARKET SIZE, BY MICROREACTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL MICROFLUIDICS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL MICROFLUIDICS MARKET SIZE, BY WEARABLE DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL MICROFLUIDICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL MICROFLUIDICS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. AMERICAS MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 43. AMERICAS MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
• TABLE 44. AMERICAS MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
• TABLE 45. AMERICAS MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 46. AMERICAS MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 47. AMERICAS MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 48. ARGENTINA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 49. ARGENTINA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 50. ARGENTINA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. ARGENTINA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 52. ARGENTINA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
• TABLE 53. ARGENTINA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
• TABLE 54. ARGENTINA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 55. ARGENTINA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 56. BRAZIL MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 57. BRAZIL MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 58. BRAZIL MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. BRAZIL MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 60. BRAZIL MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
• TABLE 61. BRAZIL MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
• TABLE 62. BRAZIL MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 63. BRAZIL MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 64. CANADA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 65. CANADA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 66. CANADA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. CANADA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 68. CANADA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
• TABLE 69. CANADA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
• TABLE 70. CANADA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 71. CANADA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 72. MEXICO MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 73. MEXICO MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 74. MEXICO MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. MEXICO MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 76. MEXICO MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
• TABLE 77. MEXICO MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
• TABLE 78. MEXICO MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 79. MEXICO MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 80. UNITED STATES MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 81. UNITED STATES MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 82. UNITED STATES MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. UNITED STATES MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 84. UNITED STATES MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
• TABLE 85. UNITED STATES MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
• TABLE 86. UNITED STATES MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 87. UNITED STATES MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 88. UNITED STATES MICROFLUIDICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 89. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 90. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 91. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 93. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
• TABLE 94. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
• TABLE 95. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 96. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 97. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 98. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 99. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 100. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 102. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
• TABLE 103. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
• TABLE 104. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 105. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 106. CHINA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 107. CHINA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 108. CHINA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. CHINA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 110. CHINA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
• TABLE 111. CHINA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
• TABLE 112. CHINA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 113. CHINA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 114. INDIA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 115. INDIA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 116. INDIA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. INDIA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 118. INDIA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
• TABLE 119. INDIA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
• TABLE 120. INDIA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 121. INDIA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 122. INDONESIA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 123. INDONESIA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 124. INDONESIA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. INDONESIA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 126. INDONESIA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
• TABLE 127. INDONESIA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
• TABLE 128. INDONESIA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 129. INDONESIA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 130. JAPAN MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 131. JAPAN MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 132. JAPAN MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. JAPAN MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 134. JAPAN MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
• TABLE 135. JAPAN MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
• TABLE 136. JAPAN MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 137. JAPAN MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 138. MALAYSIA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 139. MALAYSIA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 140. MALAYSIA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. MALAYSIA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 142. MALAYSIA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
• TABLE 143. MALAYSIA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
• TABLE 144. MALAYSIA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 145. MALAYSIA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 146. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 147. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 148. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 149. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 150. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
• TABLE 151. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
• TABLE 152. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 153. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 154. SINGAPORE MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 155. SINGAPORE MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 156. SINGAPORE MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 157. SINGAPORE MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 158. SINGAPORE MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
• TABLE 159. SINGAPORE MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
• TABLE 160. SINGAPORE MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 161. SINGAPORE MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 162. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 166. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
• TABLE 167. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
• TABLE 168. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 169. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 170. TAIWAN MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 171. TAIWAN MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 172. TAIWAN MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 173. TAIWAN MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 174. TAIWAN MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
• TABLE 175. TAIWAN MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
• TABLE 176. TAIWAN MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 177. TAIWAN MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 178. THAILAND MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 179. THAILAND MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 180. THAILAND MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 181. THAILAND MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 182. THAILAND MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
• TABLE 183. THAILAND MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
• TABLE 184. THAILAND MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 185. THAILAND MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 186. VIETNAM MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 187. VIETNAM MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 188. VIETNAM MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 189. VIETNAM MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 190. VIETNAM MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
• TABLE 191. VIETNAM MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
• TABLE 192. VIETNAM MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 193. VIETNAM MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 194. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 195. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 196. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 197. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 198. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
• TABLE 199. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
• TABLE 200. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 201. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 202. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 203. DENMARK MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 204. DENMARK MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 205. DENMARK MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 206. DENMARK MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 207. DENMARK MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
• TABLE 208. DENMARK MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
• TABLE 209. DENMARK MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 210. DENMARK MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 211. EGYPT MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 212. EGYPT MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 213. EGYPT MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 214. EGYPT MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 215. EGYPT MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
• TABLE 216. EGYPT MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
• TABLE 217. EGYPT MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 218. EGYPT MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 219. FINLAND MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 220. FINLAND MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 221. FINLAND MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 222. FINLAND MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 223. FINLAND MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
• TABLE 224. FINLAND MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
• TABLE 225. FINLAND MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 226. FINLAND MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 227. FRANCE MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 228. FRANCE MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 229. FRANCE MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 230. FRANCE MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 231. FRANCE MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
• TABLE 232. FRANCE MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
• TABLE 233. FRANCE MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 234. FRANCE MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 235. GERMANY MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 236. GERMANY MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 237. GERMANY MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 238. GERMANY MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 239. GERMANY MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
• TABLE 240. GERMANY MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
• TABLE 241. GERMANY MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 242. GERMANY MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 243. ISRAEL MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 244. ISRAEL MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 245. ISRAEL MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 246. ISRAEL MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 247. ISRAEL MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
• TABLE 248. ISRAEL MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
• TABLE 249. ISRAEL MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 250. ISRAEL MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 251. ITALY MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 252. ITALY MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 253. ITALY MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 254. ITALY MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 255. ITALY MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
• TABLE 256. ITALY MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
• TABLE 257. ITALY MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 258. ITALY MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 259. NETHERLANDS MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 260. NETHERLANDS MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 261. NETHERLANDS MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 262. NETHERLANDS MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 263. NETHERLANDS MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
• TABLE 264. NETHERLANDS MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
• TABLE 265. NETHERLANDS MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 266. NETHERLANDS MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 267. NIGERIA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 268. NIGERIA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 269. NIGERIA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 270. NIGERIA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 271. NIGERIA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
• TABLE 272. NIGERIA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
• TABLE 273. NIGERIA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 274. NIGERIA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 275. NORWAY MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 276. NORWAY MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 277. NORWAY MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 278. NORWAY MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 279. NORWAY MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
• TABLE 280. NORWAY MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
• TABLE 281. NORWAY MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 282. NORWAY MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 283. POLAND MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 284. POLAND MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 285. POLAND MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 286. POLAND MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 287. POLAND MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
• TABLE 288. POLAND MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
• TABLE 289. POLAND MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 290. POLAND MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 291. QATAR MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 292. QATAR MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 293. QATAR MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 294. QATAR MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 295. QATAR MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
• TABLE 296. QATAR MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
• TABLE 297. QATAR MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 298. QATAR MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 299. RUSSIA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 300. RUSSIA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 301. RUSSIA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 302. RUSSIA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 303. RUSSIA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
• TABLE 304. RUSSIA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
• TABLE 305. RUSSIA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 306. RUSSIA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 307. SAUDI ARABIA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 308. SAUDI ARABIA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 309. SAUDI ARABIA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 310. SAUDI ARABIA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 311. SAUDI ARABIA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
• TABLE 312. SAUDI ARABIA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
• TABLE 313. SAUDI ARABIA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 314. SAUDI ARABIA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 315. SOUTH AFRICA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 316. SOUTH AFRICA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 317. SOUTH AFRICA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 318. SOUTH AFRICA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 319. SOUTH AFRICA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
• TABLE 320. SOUTH AFRICA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
• TABLE 321. SOUTH AFRICA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 322. SOUTH AFRICA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 323. SPAIN MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 324. SPAIN MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 325. SPAIN MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 326. SPAIN MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 327. SPAIN MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
• TABLE 328. SPAIN MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
• TABLE 329. SPAIN MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 330. SPAIN MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 331. SWEDEN MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 332. SWEDEN MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 333. SWEDEN MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 334. SWEDEN MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 335. SWEDEN MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
• TABLE 336. SWEDEN MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
• TABLE 337. SWEDEN MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 338. SWEDEN MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 339. SWITZERLAND MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 340. SWITZERLAND MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 341. SWITZERLAND MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 342. SWITZERLAND MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 343. SWITZERLAND MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
• TABLE 344. SWITZERLAND MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
• TABLE 345. SWITZERLAND MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 346. SWITZERLAND MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 347. TURKEY MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 348. TURKEY MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 349. TURKEY MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 350. TURKEY MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 351. TURKEY MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
• TABLE 352. TURKEY MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
• TABLE 353. TURKEY MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 354. TURKEY MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 355. UNITED ARAB EMIRATES MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 356. UNITED ARAB EMIRATES MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 357. UNITED ARAB EMIRATES MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 358. UNITED ARAB EMIRATES MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 359. UNITED ARAB EMIRATES MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)

TABLE

The Microfluidics Market was valued at USD 25.53 billion in 2023, expected to reach USD 31.84 billion in 2024, and is projected to grow at a CAGR of 25.37%, to USD 124.31 billion by 2030.

Microfluidics, a multidisciplinary field intersecting engineering, physics, chemistry, biochemistry, nanotechnology, and biotechnology, involves the manipulation of small volumes of fluids in micro-channels. Its scope extends across various applications such as drug development, clinical diagnostics, and environmental monitoring, serving industries including healthcare, pharmaceuticals, and environmental science. The necessity of microfluidics arises from its ability to conduct high-efficiency, cost-effective analyses with reduced sample and reagent volumes, thus providing rapid results. Its applications are broad but are particularly pivotal in point-of-care testing, pathogen detection, and personalized medicine, driven by the growing demand for decentralizing healthcare services and rapid diagnostics.

Key growth factors influencing the microfluidics market include advancements in miniaturization technologies, increased funding for research and development, and the rising prevalence of chronic diseases necessitating innovative diagnostic solutions. The integration of microfluidics with AI and machine learning presents substantial opportunities, especially in developing smart, autonomous lab-on-a-chip devices. To capitalize on these opportunities, stakeholders should focus on interdisciplinary collaborations and expanding capabilities in automation and digitization.

However, challenges such as the high cost of devices, complex manufacturing processes, and stringent regulatory requirements can impede market growth. Overcoming these limitations will require strategic investments in scalable manufacturing technologies and streamlined regulatory pathways. Areas ripe for innovation include developing low-cost, user-friendly microfluidics systems for home healthcare settings, and exploring new materials like paper-based microfluidics for sustainability and cost reduction.

The microfluidics market, characterized by rapid technological advancements and a high degree of competition, offers substantial growth prospects. Companies should target strategic mergers and acquisitions to enhance their product portfolios and geographical reach. Insights indicate that as the demand for portable and rapid diagnostic solutions increases, emphasizing the development of integrated systems with enhanced sensitivity and specificity can position businesses for leadership in this evolving market landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Microfluidics Market

The Microfluidics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing Incidence of Chronic Diseases and Increasing Demand for Point-Of-Care Testing
  • Improved Portability of Devices through Microfluidic Chip Miniaturization and Faster Turn-Around Time for Analysis
  • Potential Applications of Drug Delivery using Microfluidics
• Market Restraints
  • Complicated and Time-Consuming Regulatory Approval Process
• Market Opportunities
  • Development of Microfluidic-Based 3D Cell Culture Systems such as Organ-on-a-Chip
  • Advances in Microfluidic Components for Biomedical Analysis and Diagnostics
• Market Challenges
  • Integration of Microfluidics with Existing Workflows

Porter's Five Forces: A Strategic Tool for Navigating the Microfluidics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Microfluidics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Microfluidics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Microfluidics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Microfluidics Market

A detailed market share analysis in the Microfluidics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Microfluidics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Microfluidics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Microfluidics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Ascent Bio-Nano Technologies, Inc., Camozzi Automation S.p.A., Dolomite Microfluidics, IMT Masks and Divisions AG, PerkinElmer Inc., Thermo Fisher Scientific, Inc., Mission Bio, Inc., Idex Corporation, NanoCellect Biomedical., Abaxis, Inc., Quidel Corporation, Koninklijke Philips N.V., Parker-Hannifin Corporation, Illumina, Inc., Bio-Rad Laboratories, Inc., BioFluidica, Agilent Technologies, Inc., Danaher Corporation, Biosurfit SA, SMC Corporation, Micropoint Bioscience, Inc., Fluigent S.A., Elvesys Group, Achira Labs Pvt. Ltd., Sphere Fluidics Limited, OPKO Health, Inc., Cellix Limited, AbCellera Biologics Inc., and Fluidigm Corporation by Standard BioTools Inc..

Market Segmentation & Coverage

This research report categorizes the Microfluidics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Material, market is studied across Glass-based, Polymer-based, and Silicon-based.
• Based on Component, market is studied across Micro Needle, Micro Pump, and Microfluidic Chip.
• Based on Application, market is studied across In-Vitro Diagnostics, Pharmaceutical & Life Science Research, and Therapeutics. The In-Vitro Diagnostics is further studied across Clinical Diagnostics, Point-Of-Care Testing, and Veterinary Diagnostics. The Pharmaceutical & Life Science Research is further studied across Lab Analytics, Microdispensing, and Microreaction. The Lab Analytics is further studied across Capillary Electrophoresis, Cell-based Assays, Genomic analysis, and Proteomic Analysis. The Therapeutics is further studied across Drug Delivery and Wearable Devices.
• Based on End User, market is studied across Academic & Research Institutes, Hospitals & Diagnostic Centers, and Pharmaceutical & Biotechnology Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing Incidence of Chronic Diseases and Increasing Demand for Point-Of-Care Testing
    • 5.1.1.2. Improved Portability of Devices through Microfluidic Chip Miniaturization and Faster Turn-Around Time for Analysis
    • 5.1.1.3. Potential Applications of Drug Delivery using Microfluidics
  • 5.1.2. Restraints
    • 5.1.2.1. Complicated and Time-Consuming Regulatory Approval Process
  • 5.1.3. Opportunities
    • 5.1.3.1. Development of Microfluidic-Based 3D Cell Culture Systems such as Organ-on-a-Chip
    • 5.1.3.2. Advances in Microfluidic Components for Biomedical Analysis and Diagnostics
  • 5.1.4. Challenges
    • 5.1.4.1. Integration of Microfluidics with Existing Workflows
• 5.2. Market Segmentation Analysis
  • 5.2.1. Material: Increasing use of glass and silicon-based materials for microfluidic devices
  • 5.2.2. Component: Adoption of microneedles and pumps for minimal risk of infection
  • 5.2.3. Application: Significant application of microfluidic devices in IVD and therapeutics
  • 5.2.4. End User: Emerging use of microfluidics in research organizations and hospitals & diagnostics centers
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental
• 5.5. Client Customization

6. Microfluidics Market, by Material

• 6.1. Introduction
• 6.2. Glass-based
• 6.3. Polymer-based
• 6.4. Silicon-based

7. Microfluidics Market, by Component

• 7.1. Introduction
• 7.2. Micro Needle
• 7.3. Micro Pump
• 7.4. Microfluidic Chip

8. Microfluidics Market, by Application

• 8.1. Introduction
• 8.2. In-Vitro Diagnostics
  • 8.2.1. Clinical Diagnostics
  • 8.2.2. Point-Of-Care Testing
  • 8.2.3. Veterinary Diagnostics
• 8.3. Pharmaceutical & Life Science Research
  • 8.3.1. Lab Analytics
    • 8.3.1.1. Capillary Electrophoresis
    • 8.3.1.2. Cell-based Assays
    • 8.3.1.3. Genomic analysis
    • 8.3.1.4. Proteomic Analysis
  • 8.3.2. Microdispensing
  • 8.3.3. Microreaction
• 8.4. Therapeutics
  • 8.4.1. Drug Delivery
  • 8.4.2. Wearable Devices

9. Microfluidics Market, by End User

• 9.1. Introduction
• 9.2. Academic & Research Institutes
• 9.3. Hospitals & Diagnostic Centers
• 9.4. Pharmaceutical & Biotechnology Companies

10. Americas Microfluidics Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Microfluidics Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Microfluidics Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Astraveus Raises €16.5 Million Series Seed Round to Advance the Development of its Automated, Microfluidic Cell and Gene Therapy Manufacturing Platform
  • 13.3.2. Bio-Techne to acquire Swiss spatial biology firm Lunaphore
  • 13.3.3. CellFE Announces Launch of Novel Microfluidic Cellular Engineering Platform at ASGCT 2023 Annual Meeting

Companies Mentioned

• 1. Abbott Laboratories
• 2. Ascent Bio-Nano Technologies, Inc.
• 3. Camozzi Automation S.p.A.
• 4. Dolomite Microfluidics
• 5. IMT Masks and Divisions AG
• 6. PerkinElmer Inc.
• 7. Thermo Fisher Scientific, Inc.
• 8. Mission Bio, Inc.
• 9. Idex Corporation
• 10. NanoCellect Biomedical.
• 11. Abaxis, Inc.
• 12. Quidel Corporation
• 13. Koninklijke Philips N.V.
• 14. Parker-Hannifin Corporation
• 15. Illumina, Inc.
• 16. Bio-Rad Laboratories, Inc.
• 17. BioFluidica
• 18. Agilent Technologies, Inc.
• 19. Danaher Corporation
• 20. Biosurfit SA
• 21. SMC Corporation
• 22. Micropoint Bioscience, Inc.
• 23. Fluigent S.A.
• 24. Elvesys Group
• 25. Achira Labs Pvt. Ltd.
• 26. Sphere Fluidics Limited
• 27. OPKO Health, Inc.
• 28. Cellix Limited
• 29. AbCellera Biologics Inc.
• 30. Fluidigm Corporation by Standard BioTools Inc.